Skye Bioscience, Inc. Common Stock (SKYE) — Defensive Interval Ratio
Skye Bioscience, Inc. Common Stock (SKYE) has a Defensive Interval Ratio of 63 days as of June 2026. Defensive assets of $2.00 Million (cash $-, short-term investments $2.00 Million, receivables $-) cover 63 days of daily cash needs of $31.59K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Skye Bioscience, Inc. Common Stock Defensive Interval Ratio (2012–2025)
This chart shows how Skye Bioscience, Inc. Common Stock's Defensive Interval Ratio has evolved across 7 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 63 days, meaning defensive assets of $2.00 Million can fund 63 days of operations without new revenue. For the complete balance sheet picture, see how large is Skye Bioscience, Inc. Common Stock's balance sheet.
Annual Defensive Interval Ratio for Skye Bioscience, Inc. Common Stock (2012–2025)
The table below presents the year-by-year Defensive Interval Ratio for Skye Bioscience, Inc. Common Stock from 2012 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Skye Bioscience, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 884 days | $19.87 Million | $22.48K/day | $- | $19.85 Million | ▲ +883 days |
| 2024 | 0 days | $5.07K | $11.89K/day | $- | $0.00 | ▲ +235 days |
| 2023 | -234 days | $-8.92 Million | $38.08K/day | $- | $-9.08 Million | ▼ -236 days |
| 2022 | 2 days | $74.12K | $33.20K/day | $- | $- | ▼ -21 days |
| 2015 | 24 days | $37.50K | $1.59K/day | $- | $37.50K | ▼ -27 days |
| 2013 | 51 days | $25.34K | $499.05/day | $- | $- | ▼ -957 days |
| 2012 | 1008 days | $11.94K | $11.85/day | $- | $- | — |